Nuvectis Pharma, Inc. (NVCT)

NCM – Real vaqt narxi. Valyuta: USD

19.54

+0.13 (0.67%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

19.54

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:10 PM EDT

04.08.2026

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

FORT LEE, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today reported its financial results for the second quarter of 2026 and provided an update on recent business progress.

Videolar

No Data

There is no data to display

Press-relizlar

04.08.2026

Nuvectis Pharma, Inc. (NVCT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videolar

No Data

Press-relizlar

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videolar

No Data

Press-relizlar

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Search stocks

Nuvectis Pharma, Inc. (NVCT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videolar

No Data

Press-relizlar

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Videolar

No Data

Press-relizlar

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights